Archive · 30 Jan 2026
KRM Ayurveda IPO lists at 28% premium
KRM Ayurveda, a company that runs Ayurvedic hospitals and sells herbal products, had its shares listed on the stock market on January 29.
The shares started at a price much higher than expected, giving investors a 28% profit right away.
The company raised ₹77.49 crore from this IPO, which was very popular, with many more people wanting to buy shares than were available.
The money raised will be used to improve their telemedicine services, upgrade technology, pay off debts, and cover other business needs.
KRM Ayurveda has six hospitals and five clinics in India and also offers online medical services.
They made a profit of ₹12.1 crore last year and have good financial health.
KRM Ayurveda shares listed at ₹172.10, a 28% premium over the IPO price of ₹135.
The IPO was subscribed 74.27 times, with strong demand across all investor segments.
The company raised ₹77.49 crore through the IPO, which was entirely a fresh issue of 57.40 lakh shares.
Funds will be used for expanding telemedicine, upgrading technology, repaying borrowings, and meeting working capital needs.
KRM Ayurveda operates six hospitals and five clinics in India, with 443 employees, and offers telemedicine services.
- Who
- KRM Ayurveda, an Ayurvedic healthcare and products company
- What
- Successful IPO listing at a 28% premium
- When
- January 29, 2024
- Where
- Indian stock market (NSE SME)
- Why
- To expand telemedicine, upgrade technology, repay borrowings, and meet working capital needs
Investor Optimism
Market Risk
IPO Performance
Investor Optimism
Investors are optimistic about the strong debut and premium pricing, indicating confidence in the company's growth prospects.
Market Risk
Market risks include volatility and potential difficulties in exiting positions, especially in the SME segment.
- IPO Listing Price
- ₹172.10
- IPO Issue Price
- ₹135 per share
- Premium
- 28%
- Funds Raised
- ₹77.49 crore
- Subscription
- 74.27 times
- Profit After Tax (FY25)
- ₹12.1 crore
- EBITDA Margins (Sep 2025)
- 26.54%
- Return on Net Worth (Sep 2025)
- 21.84%